Abstract
Background
Bradycardia is the most common terminal cardiac electrical activity in children, and early recognition and treatment is necessary to avoid cardiac arrest. Interventions such as oxygen, chest compressions, epinephrine, and atropine recommended by American Heart Association (AHA) Pediatric Advanced Life support (PALS) guidelines have been shown to improve outcomes (including higher survival rates) for inpatient pediatric patients with bradycardia. However, little is known about the epidemiology of pediatric prehospital bradycardia. We sought to investigate the incidence and management of pediatric bradycardia in the prehospital setting by emergency medical services (EMS).
Methods
This was a retrospective study of 911 scene response prehospital encounters for patients ages 0–18 years in 2019 from the United States ESO Research Data Collaborative. We defined age-based bradycardia per the 2015 AHA PALS guidelines. We performed general descriptive statistics and a univariate analysis examining any PALS-recommended interventions in the presence of altered mental status, hypotension for age, and a first heart rate less than 60.
Results
Of 7,422,710 encounters in the 2019 ESO Data Collaborative, 1,209 patients met inclusion criteria. Most (58.5%) were male, and the median age was 2 years (interquartile range 0–13 years). One-quarter (24.7%) of patients received fluids, and bag-valve mask ventilation was the most common airway intervention (12.1% of patients). Receipt of any PALS-recommended interventions was associated with age-adjusted hypotension (odds ratio (OR) 4.0, 95% confidence interval (CI) 3.9–5.4) and altered mental status (OR 15.5, 95% CI 10.7–22.3), but not a first heart rate less than 60 bpm (OR 0.9, 95% CI 0.6–1.1).
Conclusions
To our knowledge, this study is the first to examine the incidence and management of prehospital pediatric bradycardia. Incidence was rare, but adherence to PALS guidelines was variable. Further research and education are needed to ensure proper prehospital treatment of pediatric bradycardia.
Disclosure statement
The authors report no disclosures nor conflicts of interest. The authors alone are responsible for the content and writing of this manuscript.
Author’s contributions
Each author’s contribution to the manuscript is listed below: AH: study design and conceptualization, data interpretation, primary drafting and revision of the manuscript; RPC: study design, data interpretation, manuscript editing; JNF: study design, data analysis and interpretation, manuscript editing.